Singapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ:MNDR) (&#34;MNDR&#34; or the &#34;Company&#34;), a leading AI-powered digital health platform, today announced the signing of a non-binding

Singapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MNDR">MNDR</a>) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding ("MOU") with Hector Capital Holdings Pte. Ltd. ("Hector Capital"). Under the framework, Hector Capital will invest up to US$119 million into MNDR to support the acquisition of majority shareholdings in MILVIK Singapore Pte. Ltd. ("BIMA"), a healthcare platform operating in Asia and Africa, and M&#38;M Helix Pte. Ltd. ("MM Helix"), a healthcare technology firm offering an AI-powered telemedicine and patient care platform.This strategic partnership marks a significant milestone in MNDR's mission to expand its portfolio of AI-powered healthcare solutions across Asia and Africa.Transaction Highlights<ul style="list-style-type: disc;"><li>Capital Investment: Hector Capital to invest up to US$119 million in MNDR, with the funding structure to be finalized in the definitive agreements, which may include a combination of equity subscription, convertible instruments, and/or other financial instruments. Proceeds will be applied toward the acquisitions and for general corporate and operational purposes.</li><li>Acquisitions: MNDR to acquire majority stakes in BIMA and MM Helix, integrating them as subsidiaries.</li><li>Independent Valuation: Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix to be commissioned and agreed to by the parties prior to execution of the definitive agreements, and remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law.</li></ul>About the Targets<ul style="list-style-type: disc;"><li>M&#38;M Helix Pte. Ltd.: A Singapore-based digital healthcare technology firm offering an AI-powered telemedicine and patient care platform. MM Helix recently expanded its capabilities through the acquisition of Hyderabad-based health-tech firm Zibew, operator of DigitalRx.io, enabling a unified system for clinic and pharmacy workflows.</li><li>MILVIK BIMA: Founded in 2010, BIMA is a pioneer in democratising healthcare in emerging markets. Its platform provides affordable access to telemedicine, specialist care, health screening, personalized health programs, medicine delivery, laboratory testing, and insurance. Operating across Asia and Africa, BIMA serves millions of customers and is committed to making high-quality healthcare accessible to all.</li></ul>Strategic ValueBy combining MNDR's Nasdaq listing, market access, and operational expertise with Hector Capital's investment, ongoing strategic advisory support, and introductions to relevant business networks, the partnership will:<ul style="list-style-type: disc;"><li>Accelerate growth of BIMA and MM Helix through expanded digital health offerings.</li><li>Enhance efficiency by leveraging MNDR's AI-driven tele-consultation and workflow automation.</li><li>Broaden access to affordable healthcare across Asia and Africa.</li></ul>Dr. Siaw Tung Yeng, Co-CEO of MNDR, commented, "This framework sets the stage for transformative growth. By integrating BIMA's healthcare ecosystem and MM Helix's AI-powered platform into MNDR, we are building a scalable, affordable healthcare network that empowers millions of families across emerging markets."Vikash, representing Hector Capital Holdings, added, "Our investment underscores confidence in MNDR's vision. Together, we will unlock synergies that drive profitability, reduce costs through AI, and expand access to healthcare globally."The MOU is strictly non-binding in its entirety and serves as the basis for negotiating definitive agreements, including an Investment Agreement and Share Purchase Agreements. Completion remains subject to MNDR's full legal, financial, and operational due diligence on BIMA and MM Helix, independent valuation, and receipt of all necessary regulatory approvals, including those required under applicable Nasdaq listing rules and Singapore law.About Hector Capital HoldingsHector Capital Holdings Pte. Ltd. is a Singapore-based investment firm with substantial indirect and beneficial shareholdings in regulated fund management entities VPAM and Brown Capital, operating across multiple jurisdictions. The firm specializes in strategic investments that combine capital deployment with operational value-add, supporting portfolio companies in scaling across Asia and beyond.Through majority ownership interests in MILVIK Singapore Pte. Ltd. (BIMA) and M&#38;M Helix Pte. Ltd., Hector Capital has built a strong presence in the digital healthcare sector. Its investment philosophy emphasizes:<ul style="list-style-type: disc;"><li>Long-term growth through technology-driven healthcare solutions.</li><li>Cross-border structuring to enable expansion into emerging markets.</li><li>Strategic partnerships that leverage both financial strength and advisory expertise.</li></ul>By partnering with MNDR, Hector Capital is reinforcing its commitment to democratizing healthcare access and accelerating the adoption of AI-powered platforms that improve patient outcomes and operational efficiency.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.<div id="contactInfo">For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange Singapore 608526 (+65) 6222 5223 Email: <a href="mailto:investors@manadr.com">investors@manadr.com</a>Investor Relations Inquiries:Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, New York 10036 Office: (646) 893-5835 Email: <a href="mailto:ir@skylineccg.com">ir@skylineccg.com</a></div><img src="https://images.newsfilecorp.com/files/10584/295749_mobilehealthnetworksolutionslogo_200.jpg" alt="Corporate Logo" id="corporateNewsLogo" />To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/B54xJFPoxW">https://www.newsfilecorp.com/release/295749</a><img src="https://api.newsfilecorp.com/newsinfo/295749/197" alt="" />

MNDR

Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa

MNDR Secures $119 Million Investment to Expand AI Healthcare Initiatives

<section class="insight" data-version="1">
 <section data-block="information">
 <h3>Information</h3>
 Singapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ:MNDR) (&amp;#34;MNDR&amp;#34; or the &amp;#34;Company&amp;#34;), a leading AI-powered digital health platform, today announced the signing of a non-binding
 </section>

 <section data-block="ai-summary-paragraph">
 <h3>AI Summary</h3>
 Mobile-health Network Solutions (MNDR) has signed a non-binding MOU with Hector Capital for a significant investment of up to $119 million. This funding will facilitate the acquisition of BIMA and MM Helix, boosting MNDR&#039;s expansion in AI-driven healthcare across Asia and Africa, with potential for substantial growth in customer base and revenue.
 </section>

 <section data-block="ai-summary-bullets">
 <h3>Key Points</h3>
 <ul><li>MNDR announces a non-binding MOU with Hector Capital for $119 million investment.</li><li>Investment targets acquisitions of BIMA and MM Helix to expand operations.</li><li>Proceeds from investment will support acquisitions and corporate purposes.</li><li>Partnership aims to grow AI-powered healthcare offerings in Asia and Africa.</li><li>Completion remains subject to requisite regulatory approvals and valuations.</li></ul>
 </section>

 <section data-block="companies-mentioned">
 <h3>Companies Mentioned</h3>
 <ul><li>Hector Capital Holdings (N/A): Investment firm supporting MNDR&#039;s growth in digital healthcare.</li><li>MILVIK Singapore Pte. Ltd. (BIMA) (N/A): Pioneering affordable healthcare solutions in Asia and Africa.</li><li>M&amp;M Helix Pte. Ltd. (N/A): Offers AI telemedicine solutions, enhancing MNDR&#039;s technical capabilities.</li></ul>
 </section>

 <section data-block="category">
 <h3>Corporate Developments</h3>
 This news falls under &#039;Corporate Developments&#039; as it involves a significant investment and strategic partnership, indicating potentially transformative growth for MNDR. The combination of funding and acquisition enhances MNDR&#039;s operational scale and market reach in AI-driven healthcare services.
 </section>

 <section data-block="market-moving">
 <h3>Market-Moving</h3>
 <ul><li>Investment of $119 million could rapidly increase MNDR&#039;s market positioning.</li><li>Successful acquisitions may lead to enhanced revenue flows from expanded services.</li><li>Regulatory approvals are critical; delays may dampen investor sentiment.</li><li>Positive operational synergies from AI integration could improve margins significantly.</li></ul>
 </section>

 <section data-block="key-facts">
 <h3>Key Facts</h3>
 <ul><li>Hector Capital to invest up to $119 million in MNDR.</li><li>MNDR will acquire majority stakes in BIMA and MM Helix as subsidiaries.</li><li>Independent valuations will precede acquisition agreements.</li><li>Partnership focuses on enhancing healthcare access across Asia and Africa.</li><li>Acquisitions are subject to regulatory approvals under Nasdaq and Singapore law.</li></ul>
 </section>

 <section data-block="trading-thesis">
 <h3>Trading Thesis</h3>
 Buy MNDR on favorable expansion prospects driven by new investment, target in 12 months.
 </section>
</section>


Singapore, Singapore--(Newsfile Corp. - May 4, 2026) - Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/MNDR">MNDR</a>) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced the signing of a non-binding Strategic Cooperation Framework Memorandum of Understanding ("MOU") with Hector Capital Holdings Pte. Ltd. ("Hector Capital"). Under the framework, Hector Capital will invest up to US$119 million into MNDR to support the acquisition of majority shareholdings in MILVIK Singapore Pte. Ltd. ("BIMA"), a healthcare platform operating in Asia and Africa, and M&#38;M Helix Pte. Ltd. ("MM Helix"), a healthcare technology firm offering an AI-powered telemedicine and patient care platform.This strategic partnership marks a significant milestone in MNDR's mission to expand its portfolio of AI-powered healthcare solutions across Asia and Africa.Transaction Highlights<ul style="list-style-type: disc;"><li>Capital Investment: Hector Capital to invest up to US$119 million in MNDR, with the funding structure to be finalized in the definitive agreements, which may include a combination of equity subscription, convertible instruments, and/or other financial instruments. Proceeds will be applied toward the acquisitions and for general corporate and operational purposes.</li><li>Acquisitions: MNDR to acquire majority stakes in BIMA and MM Helix, integrating them as subsidiaries.</li><li>Independent Valuation: Consideration for the acquisitions will be consistent with an independent valuation of BIMA and MM Helix to be commissioned and agreed to by the parties prior to execution of the definitive agreements, and remains subject to regulatory approvals under applicable Nasdaq listing rules and Singapore law.</li></ul>About the Targets<ul style="list-style-type: disc;"><li>M&#38;M Helix Pte. Ltd.: A Singapore-based digital healthcare technology firm offering an AI-powered telemedicine and patient care platform. MM Helix recently expanded its capabilities through the acquisition of Hyderabad-based health-tech firm Zibew, operator of DigitalRx.io, enabling a unified system for clinic and pharmacy workflows.</li><li>MILVIK BIMA: Founded in 2010, BIMA is a pioneer in democratising healthcare in emerging markets. Its platform provides affordable access to telemedicine, specialist care, health screening, personalized health programs, medicine delivery, laboratory testing, and insurance. Operating across Asia and Africa, BIMA serves millions of customers and is committed to making high-quality healthcare accessible to all.</li></ul>Strategic ValueBy combining MNDR's Nasdaq listing, market access, and operational expertise with Hector Capital's investment, ongoing strategic advisory support, and introductions to relevant business networks, the partnership will:<ul style="list-style-type: disc;"><li>Accelerate growth of BIMA and MM Helix through expanded digital health offerings.</li><li>Enhance efficiency by leveraging MNDR's AI-driven tele-consultation and workflow automation.</li><li>Broaden access to affordable healthcare across Asia and Africa.</li></ul>Dr. Siaw Tung Yeng, Co-CEO of MNDR, commented, "This framework sets the stage for transformative growth. By integrating BIMA's healthcare ecosystem and MM Helix's AI-powered platform into MNDR, we are building a scalable, affordable healthcare network that empowers millions of families across emerging markets."Vikash, representing Hector Capital Holdings, added, "Our investment underscores confidence in MNDR's vision. Together, we will unlock synergies that drive profitability, reduce costs through AI, and expand access to healthcare globally."The MOU is strictly non-binding in its entirety and serves as the basis for negotiating definitive agreements, including an Investment Agreement and Share Purchase Agreements. Completion remains subject to MNDR's full legal, financial, and operational due diligence on BIMA and MM Helix, independent valuation, and receipt of all necessary regulatory approvals, including those required under applicable Nasdaq listing rules and Singapore law.About Hector Capital HoldingsHector Capital Holdings Pte. Ltd. is a Singapore-based investment firm with substantial indirect and beneficial shareholdings in regulated fund management entities VPAM and Brown Capital, operating across multiple jurisdictions. The firm specializes in strategic investments that combine capital deployment with operational value-add, supporting portfolio companies in scaling across Asia and beyond.Through majority ownership interests in MILVIK Singapore Pte. Ltd. (BIMA) and M&#38;M Helix Pte. Ltd., Hector Capital has built a strong presence in the digital healthcare sector. Its investment philosophy emphasizes:<ul style="list-style-type: disc;"><li>Long-term growth through technology-driven healthcare solutions.</li><li>Cross-border structuring to enable expansion into emerging markets.</li><li>Strategic partnerships that leverage both financial strength and advisory expertise.</li></ul>By partnering with MNDR, Hector Capital is reinforcing its commitment to democratizing healthcare access and accelerating the adoption of AI-powered platforms that improve patient outcomes and operational efficiency.About Mobile-health Network SolutionsMobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit our website.Forward-Looking StatementsCertain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.<div id="contactInfo">For media inquiries, please contact:Mobile-health Network Solutions Investor Relations Contact:2 Venture Drive, #07-08 Vision Exchange Singapore 608526 (+65) 6222 5223 Email: <a href="mailto:investors@manadr.com">investors@manadr.com</a>Investor Relations Inquiries:Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, New York 10036 Office: (646) 893-5835 Email: <a href="mailto:ir@skylineccg.com">ir@skylineccg.com</a></div><img src="https://images.newsfilecorp.com/files/10584/295749_mobilehealthnetworksolutionslogo_200.jpg" alt="Corporate Logo" id="corporateNewsLogo" />To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/B54xJFPoxW">https://www.newsfilecorp.com/release/295749</a><img src="https://api.newsfilecorp.com/newsinfo/295749/197" alt="" />

Mobile-health Network Solutions (MNDR) has signed a non-binding MOU with Hector Capital for a significant investment of up to $119 million. This funding will facilitate the acquisition of BIMA and MM Helix, boosting MNDR's expansion in AI-driven healthcare across Asia and Africa, with potential for substantial growth in customer base and revenue.

mobile-health-network-solutions-enters-into-non-binding-us-119-million-strategic-framework-with-hector-capital-to-acquire-bima-and-m-m-helix-accelerating-ai-powered-healthcare-expansion-across-asia-and-africa

Mobile-health Network Solutions Enters into Non-Binding US$119 Million Strategic Framework with Hector Capital to Acquire BIMA and M&M Helix, Accelerating AI-powered Healthcare Expansion across Asia and Africa

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News